308
Participants
Start Date
July 31, 2007
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
Selegiline Transdermal System
EMSAM 6mg, 9mg, or 12mg Flexible Dose- 1 patch/24 hours- 12 Week Study
Placebo
Matching Placebo for EMSAM 6mg, 9mg, or 12mg Flexible Dose- 1 patch/24 hours- 12 Week Study
Dr. Nelson Handal, Dothan
Dr. Mohammed Bari, National City
Dr. Michael McManus, San Diego
Dr. Elias Sarkis, Gainesville
Dr. Scott Segal, North Miami
Dr. Mary Stedman, Tampa
Dr. Irving Kolin, Winter Park
Dr. Rory Murphy, Overland Park
Dr. Andrew Sediloo, Owensboro
Dr. Bruce Waslick, Springfield
Dr. Christopher Kratochvil, Omaha
Dr. Ann Childress, Las Vegas
Dr. Melissa DelBello, Cincinnati
Dr. Leland Dennis, Oklahoma City
Dr. David Brown, Austin
Dr. Alain Katic, Bellaire
Dr. Graham Emslie, Dallas
Dr. Mary Shemo, Charlottesville
Dr. John Gilliam, Richmond
Dr. Arifulla Khan, Bellevue
Lead Sponsor
Somerset Pharmaceuticals
INDUSTRY